Ankara Bilkent City Hospital
Ankara, Ankara, Çankaya, 06800, Turkey (Türkiye)
NCT Number: NCT06669676
In this study, the hypothesis that bilateral acupuncture needling at the Neiguan (PC6) point during the intraoperative period, in addition to the 0.15 mg/kg dose of ondansetron (5-HT3 antagonist) frequently used for postoperative nausea and vomiting (PONV) prophylaxis in patients undergoing lumbar disc herniation surgery, would reduce the incidence of PONV was investigated. PONV was defined as the presence of nausea and vomiting within 24 hours postoperatively.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Ankara, Ankara, Çankaya, 06800, Turkey (Türkiye)
The study will include patients aged 18 years and over, with (American Society of Anesthesiologists) ASA physical status I to II, and scheduled for one or two-level lumbar disc herniation surgery under general anesthesia. Patient characteristics (age, gender, body mass index, etc.) and postoperative nausea and vomiting (PONV) risk factors such as history of PONV, motion sickness, and history of not smoking will be recorded. The primary outcome parameter will be the incidence of PONV within 24 hours postoperatively. The severity of nausea in patients who develop nausea in the postoperative period will be assessed using a Likert scale between 0 and 10. PONV will be defined as vomiting, significant nausea (numerical rating scale [NRS] ≥4), and/or need for rescue medication. Patients will be assessed for PONV at 0, 2, 4, 12, and 24 hours using a Likert scale. Emetic attacks, pain and severity of pain, nausea and severity of nausea, need for additional analgesics, and administration of antiemetic rescue medication will be assessed as secondary outcome parameters. The severity of pain and nausea in patients who develop postoperative pain will be assessed using an 11-point numerical rating scale, where '0' indicates the absence of symptoms and '10' indicates the maximum severity. PONV within the first two hours will be defined as 'early', and within 2-24 hours after awakening will be defined as 'late'. Nausea will be defined as the desire to vomit, and vomiting will be defined as the forceful expulsion of stomach contents.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
patients will be given acupuncture in addition to standard medical treatment to prevent ponv
patients will be given standard medical treatment to prevent ponv
Time frame: 24 hours
The primary outcome of the study was the incidence of postoperative nausea and/or vomiting
Time frame: 24 hours
The degree of nausea was evaluated using the visual analogue scale (VAS), with 0 indicating no nausea or vomiting and 10 indicating the most severe form of unbearable nausea or vomiting. When the PONV score was greater than 4 or vomiting occurs
Time frame: 24 hours
11-point numerical rating scale for pain (0='no pain' and 10='worst pain possible pain') were explained.
Time frame: 24 hours
Number of additional emetic applications
Ankara City Hospital Bilkent
Other
Effect of Acupuncture on Postoperative Nausea and Vomiting in Lumbar Disc Herniation Surgeries
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06710457
Anesthesia, Nausea
Ankara, Ankara, Çankaya, Turkey (Türkiye)
View Trial DetailsNCT06357234
Anesthesia, Bone Diseases
Halifax, Nova Scotia, Canada
View Trial DetailsNCT07133048
Anesthesia, Nausea
Rijeka, Croatia
View Trial DetailsNCT06253052
Anesthesia, Aspiration
Würzburg, Bavaria, Germany
View Trial Details